6663 results about "Implant" patented technology

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

The invention discloses a test system and method for an artificial heart valve implant, and relates to the technical field of medical instrument detection. The system comprises a ventricle simulator, an atrium simulator, a circulation loop, a high-speed camera and a laser generator, wherein an artificial heart valve is arranged in the high-transparency compliance valve testing cavity, and the circulation loop is composed of a blood vessel compliance simulator and a blood vessel damping simulator. The circulation loop simulates a blood flowing environment for the artificial heart valve, and a flowing medium is added with tracer particle turbid liquid; the ventricle simulator, the atrium simulator, the vascular damper and the vascular compliance simulator respectively provide power, storage space, resistance and pulse pressure for the flowing medium; and the laser generator and the high-speed camera act together to obtain a particle image behind the artificial heart valve. The particle image is uploaded to a computer for heart valve pulsating flow field visualization analysis based on the digital particle image velocity measurement technology, and therefore quantitative analysis of the risk after the heart valve is implanted into the expected position is achieved.

A stabilization implant comprising: an elongated body having a distal end, a proximal end and a longitudinal axis extending between the distal end and the proximal end, the elongated body being characterized by a superior body surface and an inferior body surface; a superior stabilizer extending outwardly from the superior body surface, the superior stabilizer being characterized by a first lateral superior stabilizer surface and a second lateral superior stabilizer surface; and an inferior stabilizer extending outwardly from the inferior body surface, the inferior stabilizer being characterized by a first lateral inferior stabilizer surface and a second lateral inferior stabilizer surface; wherein at least one of the first lateral superior stabilizer surface, the second lateral superior stabilizer surface, the first lateral inferior stabilizer surface, and the second lateral inferior stabilizer surface comprise at least one outwardly-extending tab.

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

The invention discloses a separated modular anchor implantation system with a line, and relates to the technical field of medical apparatuses and instruments. The separated modular suture anchor implanting system comprises an inserter and a storage box, the inserter comprises an insertion rod, and an insertion part is arranged at the head of the insertion rod. An anchor and a suture line are stored in the storage box, an inlet and an outlet are formed in the two ends of the storage box respectively, and the insertion rod can be inserted into the storage box through the inlet, so that the insertion part is connected with the anchor in an inserted mode, the anchor is pushed out of the outlet, and the assembly of the inserter and the anchor is completed; after the anchor nail is implanted by the inserter, the insertion part and the anchor nail can be disconnected and the suture line can be directly withdrawn by moving the inserter in the direction opposite to the implanting direction without being removed by a doctor, so that independent storage of the anchor nail and the suture line is realized, and meanwhile, free assembly of the anchor nail and the inserter is realized; due to the modular structural design, the anchor can be selected and matched according to actual operation requirements, the inserter can be repeatedly used, waste of medical resources is reduced, and environmental protection is facilitated.

Systems and methods for sequential deployment of a prosthetic valve using a delivery catheter are described. The delivery catheter may include a deployment assembly including an end cone, a distal sleeve, a prosthetic support, an anchor sleeve and an anchor support. The delivery catheter may further include a handle having a manipulator including a guide that is connect to the deployment assembly with a force transmission tube. The guide may have various channels for interfacing with a protrusion of the handle and may be guided by the protrusion to sequentially deploy the prosthetic valve from the deployment assembly. For example, the guide may cause the distal sleeve to release a distal end of the prosthetic valve and subsequently cause an anchor support to release a proximal end of the prosthetic valve.

Implants for the fusion or fixation of two bone segments are described. For example, the implants can be used for the fusion or fixation of the sacroiliac joint. The implants can have a matrix structure, have a rectilinear cross-sectional area, and have a curvature.

Implants, implant systems, and methods for treatment of mitral valve regurgitation and other valve diseases generally include a coaptation assist body which remains within the blood flow path as the leaflets of the valve move, the valve bodies often being relatively thin, elongate (along the blood flow path), and / or conformable structures which extend laterally from commissure to commissure, allowing the native leaflets to engage and seal against the large, opposed surfaces on either side of the valve body during the heart cycle phase when the ventricle contracts to empty that chamber of blood, and allows blood to pass around the valve body so that blood flows from the atrium to the ventricle during the filling phase of the heart cycle. Separate deployment of independent anchors near each of the commissures may facilitate positioning and support of an exemplary triangular valve body, with a third anchor being deployed in the ventricle. An outer surface of the valve body may accommodate tissue ingrowth or endothelialization, while a fluid-absorbing matrix can swell after introduction into the heart. The valve body shape may be selected after an anchor has been deployed, and catheter-based deployment systems may have a desirable low profile.

There is disclosed a packaged allograft implant configured for implantation in a human recipient. In an embodiment, the packaged allograft implant includes an acellular dermal matrix sheet having a top surface and a bottom surface in opposition to one another, a perimeter surrounding the top surface and the bottom surface, and a thickness extending between the top surface and the bottom surface. The packaged allograft implant further includes a mesh pattern extending across at least a portion of the top surface and the bottom surface of the acellular dermal matrix sheet, the mesh pattern providing through-holes extending between the top surface and the bottom surface of the acellular dermal matrix sheet, and the mesh pattern having a plurality of mesh lines extending in a first direction and a second direction. The first direction and the second direction are orthogonal to one another so as to allow a given amount of stretch in each of the first direction and the second direction. Other embodiments are also disclosed.

Apparatus and methods for an implant are provided. The implant may have a constrained configuration and a relaxed configuration. The implant may include a strut having an end that may be captured by a hub and may define a reference angle in the relaxed configuration. The implant may include a swivel body that may engage a shaft of a delivery cable and may be rotated through the reference angle. The apparatus may include a pusher catheter to push the implant. The delivery cable may engage the implant. The apparatus may include gauge handle that may include a force gauge to indicate the presence of a force acting on the implant. The apparatus may include a bushing that may be fixed to an end of a pusher catheter. The bushing may move along a delivery catheter lumen and may guide the implant to a keyed position at the bushing.

Expandable fusion devices, systems, instruments, and methods thereof. The expandable fusion implant may include an upper endplate and a lower endplate configured to engage adjacent vertebrae, an actuation gear configured to adjust a height of the upper endplate, an interface collar configured to attach to an inserter instrument at multiple orientations for a desired surgical approach, and an expansion and orientation lock configured to lock the orientation of the interface collar and lock the height of the upper endplate. The expandable fusion device is attachable to the inserter instrument to secure the interface collar and disengage the lock from the actuation gear to permit expansion of the upper endplate.

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

A surgical robot a chassis includes a first surgical robotic arm and a reference device on a chassis. The first surgical robotic arm carries a surgical object, such as an implant, tool, or assembly, and the reference device carries indicia for identifying, sizing, calibrating, modeling, or verifying the surgical object. A controller kinematically positions the first surgical robotic arm to locate the implant, tool, or assembly in a predetermined orientation relative to the reference device in a surgical robotic coordinate space, and a camera is positioned to view the implant, tool, or assembly, when in proximity to the reference device.

A wireless implant and associated system for motor function recovery after spinal cord injury, and more particularly a multi-channel wireless implant with small package size. The wireless implant can further be used in various medical applications, such as retinal prostheses, gastrointestinal implant, vagus nerve stimulation, and cortical neuromodulation. The system also includes a method and its implementation to acquire the impedance model of the electrode-tissue interface of the implant.

Apparatus and methods for an implant are provided. The implant may have a constrained configuration and a relaxed configuration. The implant may include an outer stent and an inner valve support. The inner valve support may be positioned within the outer stent. The implant may include a transition section spanning between the outer stent and the inner valve support.

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

Embodiments described herein relate to an implant delivery system for delivering an implant for reducing heart valve regurgitation. The implant delivery system may include an implant catheter disposed in an inner lumen of a guide catheter. The implant catheter may include one or more hypotubes disposed therein, each hypotube configured to receive an elongate member such as a braided tether. A distal end of the implant catheter may be coupled to an implant holder configured to receive the implant. The implant holder may define one or more channels, each channel configured to receive a portion of a respective elongate member. The elongate members configured to couple the implant to the implant holder and transition the implant between configurations. The implant configured to be disposed around a portion of a leaflet of a heart valve to improve coaptation of the heart valve.

Disclosed herein are drug delivery devices and methods for the treatment of ocular disorders requiring targeted and controlled administration of a drug to an interior portion of the eye for reduction or prevention of symptoms of the disorder. The devices are capable of controlled release of one or more drugs and may also include structures which allow for treatment of increased intraocular pressure by permitting aqueous humor to flow out of the anterior chamber of the eye through the device.

A catheter implant system (61) and related devices, prosthetic heart valves (65, 7200) and methods included therein, relating to the technical field of medical instruments wherein an interventional delivery system (1, 51) included therein comprises a catheter assembly (30, 54, 64) and a control handle (9, 20, 53, 63, 63a, 63b) connected to the catheter assembly (30, 54, 64), the catheter assembly (30, 54 and 64) is provided with a far end and a near end which are opposite to each other and comprises an inner sheathing canal (320) and an outer sheathing canal (310, 544 and 644) which are sleeved with each other in a sliding mode, the outer sheathing canal (310, 544 and 644) sequentially comprises a loading section (3102) and a sheathing canal section (3103) from the far end to the near end, and the loading section (3102) is used for wrapping the interventional instrument and keeping the interventional instrument in a compressed state; the control handle (9, 20, 53, 63, 63a, 63b) comprises: a main handle (10) to which the proximal end of the inner sheath (320) is connected; the auxiliary handle (20) is arranged on the periphery of the inner sheath tube (320) in a sliding and sleeving mode, and the near ends of the outer sheath tubes (310, 544 and 644) are connected to the auxiliary handle (20).

A method and apparatus for coupling a soft tissue implant into a looking cavity formed within a bone is disclosed. A bone engaging fastener is coupled to bone. A second fastener is coupled to a suture construction. The second fastener is coupled to the first fastener. Soft tissue is coupled to the suture construction.

An implantable device or implant is configured to be positioned within a native heart valve to allow the native heart valve to form a more effective seal. The implantable device can be removed using one or more of a cutting device, a capture device, and a stabilization component. The stabilization component can control the position of the implantable device while the cutting device resects one or more of the leaflets to which the implantable device is engaged.

The present invention relates generally to implants used in medical procedures such as bone fixation or fusion. More specifically, this application relates to fenestrated implants used in bone fixation or fusion.

A magnet system including a non-magnetic spacer, a hermetically sealed case, and at least one magnet located within the hermetically sealed case as well as associated cochlear implants and associated methods.

An expandable intervertebral implant may include a superior endplate configured to engage a superior vertebra, and an inferior endplate configured to engage an inferior vertebra, wherein the inferior endplate may be spaced apart from the superior endplate by a gap. The expandable intervertebral implant may further include a first slider moveable along a first direction to urge linear expansion of the gap, and one or more cams each coupled to the first slider. The one or more cams may be configured to urge angular expansion of the gap in response to at least one of: rotation of the one or more cams about a rotation axis, and motion of the one or more cams along the first direction.

A flexible delivery catheter can be used to deploy valve repair and replacement devices at an implant site for the repair or replacement of poorly functioning native heart valves. Such a catheter can include a flexible tube having a plurality of links. A control wire can be connected to the plurality of links, such that applying tension to the control wire causes the flexible tube to bend.

An implantable device or implant is configured to be positioned within a native heart valve to allow the native heart valve to form a more effective seal. The implantable device or implant can expand and contract. For example, the implantable device or implant can narrow during delivery and expand on implantation on the native heart valve.

Various embodiments of implant systems and related apparatus, and methods of operating the same are described herein. In various embodiments, an intermedullary implant for interfacing with a bone structure includes a web structure, including a space truss, configured to interface with human bone tissue. The space truss includes two or more planar truss units having a plurality of struts joined at nodes. Implants are optimized for the expected stress applied at the bone structure site.

The invention belongs to the technical field of medical materials, and relates to a titanium-based implant surface dual drug release system and a preparation method and application thereof. Comprising a titanium-based implant and a hydrogel layer attached to the surface of the titanium-based implant, the surface of the titanium-based implant is of a nanotube array structure, zinc oxide nanoparticles and up-conversion luminescent material particles are arranged between the titanium-based implant and the hydrogel layer, and MgO2 nanoparticles are loaded in the hydrogel layer; wherein the material of the up-conversion luminescent material particles is NaYF4: Yb < 3 + >, Er < 3 + >, and the hydrogel layer is composed of gelatin-sodium alginate hydrogel. The titanium-based implant surface dual-drug release system provided by the invention can realize loading of different drugs, can be used for treating various diseases, has a better time sequence control effect, is long in action time and low in cost, and has a wide application prospect.

An apparatus method for leveraging a repository of images containing implant devices in a human body are disclosed. The apparatus includes at least a processor and a memory communicatively connected to the at least a processor, wherein the memory contains instructions configuring the at least a processor to receive a plurality of sets of historical subject data, classify the plurality of sets of historical subject data into one or more implant cohorts, generate implant training data using the plurality of sets of classified historical subject data in the one or more implant cohorts, train an implant machine-learning model using the implant training data, receive an inquiry datum from a user, wherein the inquiry datum includes current subject data and generate an output datum as a function of the inquiry datum using the trained implant machine-learning model.